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Labeling biomolecules with fluorescent labels is an established tool for structural,
biochemical, and biophysical studies; however, it remains underused for small
peptides. In this work, an amino acid bearing a 3-hydroxychromone fluorophore, 2-
amino-3-(2-(furan-2-yl)-3-hydroxy-4-oxo-4H-chromen-6-yl)propanoic acid (FHC), was
incorporated in a known hexameric antimicrobial peptide, cyclo[RRRWFW] (cWFW), in
place of aromatic residues. Circular dichroism spectropolarimetry and antibacterial activity
measurements demonstrated that the FHC residue perturbs the peptide structure
depending on labeling position but does not modify the activity of cWFW significantly.
FHC thus can be considered an adequate label for studies of the parent peptide. Several
analytical and imaging techniques were used to establish the activity of the obtained
labeled cWFW analogues toward animal cells and to study the behavior of the peptides in a
multicellular organism. The 3-hydroxychromone fluorophore can undergo excited-state
intramolecular proton transfer (ESIPT), resulting in double-band emission from its two
tautomeric forms. This feature allowed us to get insights into conformational equilibria of
the labeled peptides, localize the cWFW analogues in human cells (HeLa and HEK293) and
zebrafish embryos, and assess the polarity of the local environment around the label by
confocal fluorescence microscopy. We found that the labeled peptides efficiently
penetrated cancerous cells and localized mainly in lipid-containing and/or other
nonpolar subcellular compartments. In the zebrafish embryo, the peptides remained in
the bloodstream upon injection into the cardinal vein, presumably adhering to lipoproteins
and/or microvesicles. They did not diffuse into any tissue to a significant extent during the
first 3 h after administration. This study demonstrated the utility of fluorescent labeling by
double-emission labels to evaluate biologically active peptides as potential drug
candidates in vivo.
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INTRODUCTION
Antimicrobial peptides (AMPs) have received growing attention
from the medicinal chemistry community in recent decades, as
AMPs offer solutions to problems caused by acquired microbial
resistance to conventional antibiotics, and they tend to
demonstrate a broad spectrum (i.e., species-nonselective)
antibacterial activities (Bahar and Ren, 2013; Mantravadi et al.,
2019). Of particular interest is the well-documented antibiotic
activity against persistent, biofilm-forming microorganisms
(Berditsch et al., 2019). Among the peptides considered
promising candidates for further development into
antibacterial drugs, the cyclic arginine-/tryptophan-rich
peptide cyclo[RRRWFW] (cWFW, Figure 1A and Table 1)
stands out due to its prominent features. This peptide is one
of the smallest known AMPs. It possesses enhanced biostability
and remarkable selectivity against prokaryotic cells, and it
effectively kills Gram-positive and Gram-negative bacteria
through a unique mechanism of action that is unlikely to
induce bacterial resistance (Peschel and Sahl, 2006). Several
structural and mechanistic studies (Wessolowski et al., 2004;
Appelt et al., 2005; Appelt et al., 2008; Junkes et al., 2008;
Scheinpflug et al., 2015; Scheinpflug et al., 2017) have
demonstrated that cWFW triggers a substantial reduction in
cell membrane fluidity, resulting in anionic lipid clustering
and membrane protein segregation. This leads to severe
dysregulation of membrane functions and eventually to
prokaryotic cell autolysis. The unique mode of action, high
bactericidal potency, low hemolytic activity, and synthetic
availability make cWFW a viable antibacterial drug candidate,
justifying further studies of its behavior in vivo.
Amphiphilic AMPs, including cWFW, are membrane-active
compounds; hence, they possess tremendous potential for activity
toward not only prokaryotes but also other cell types and
multicellular organisms. In particular, AMPs are now
recognized as a rich source of oncolytic drug candidates or
can also be used for intracellular drug delivery (Mader and
Hoskin, 2006; Hoskin and Ramamoorthy, 2008; Riedl et al.,
2011; Gaspar et al., 2013; Mohd et al., 2015). Despite recent
success in developing drug candidates based on membrane-active
AMPs (Felício et al., 2017; Ryu et al., 2021), fundamental studies
on the modes and mechanisms of AMP interactions with
eukaryotic cells and tissues still lag behind the studies of their
antibacterial action. The studies that address the toxicity of AMPs
toward different host cells and tissues are still scarce in the public
domain. In most cases, such studies are limited to the estimation
of erythrolysis. In this work, as one of the prime objectives, we
examined human cell cytotoxicity of the cWFW and its cellular
uptake in broader settings. We prepared the cWFW analogues
labeled with a fluorescent amino acid residue and carried out in
FIGURE 1 | (A) Structure of the antimicrobial peptide cWFW with colour-highlighted aromatic residues that were individually substituted by the fluorescent label in
this study; (B) the fluorescent amino acid FHC used as the label (framed and colored) along with potential alternatives, i.e., reported fluorescent amino acids with the
excitation wavelengths higher than 360 nm. Compounds are designated according to original reports, excitation wavelengths (“Ex.”) are stated; (C) excited-state
intramolecular proton transfer (ESIPT)-mediated fluorescence, causing dual emission and environmental sensitivity of the chromophore in 3-hydroxychromone-
containing labels. N (N*) and T (T*) represent normal and tautomeric forms, respectively, in the ground (excited) state; BPT denotes back proton transfer in the
ground state.
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vivo observations of the analogues using not only a representative
human cancer line and noncancerous cells, but also Danio rerio
(zebrafish) embryos as a multicellular animal model organism.
Unnatural fluorescent amino acids have been successfully used
for labeling large proteins and elongated polypeptides and for
their consecutive observation in cells and tissues by fluorescent
microscopy (Lee, 2019; Cheng et al., 2020; Laxman et al., 2021).
However, in the case of short peptides which possess less than 20
amino acid residues, the applicability of this potent exploration
tool is hampered by severe structural and functional
perturbations often caused by the label. As previous studies
have shown, small hexameric cWFW is particularly sensitive
to such perturbations (Scheinpflug et al., 2013); therefore,
cWFW labeling presents a considerable challenge. This
sensitivity and our intention to use the labeled analogues for
studies in living objects prompted us to choose the fluorescent
amino acid for the labeling very carefully.
First, although many unnatural fluorescent amino acids exist
and multiple biomolecular assays and post mortem imaging
applications have been reported in the literature (Toseland,
2013; Cheng et al., 2020), they were surprisingly rarely
reasonably exploited in vivo. The cause is that many reported
fluorescent amino acids possess excitation maxima in the short-
wavelength ultraviolet (UV) range, detrimental to live cells.
Therefore, we upfront considered the known fluorescent
amino acids with high fluorescence quantum yield and
excitation maxima above 350–360 nm. We were surprised that
only a few of them had been reported in peptides, and none of the
peptides has been investigated simultaneously in structural and
functional assays. In most reports, either the function of a
fluorescent analogue has not been compared with the
prototype peptide, or a structural evaluation has been omitted
(Figure 1B).
Second, for our study, we decided to use 2-furanyl-3-
hydroxychromone-derived amino acid FHC, as it is a double-
emission label. It has been demonstrated previously as an efficient
probe in characterizing peptide-DNA interactions (Strizhak et al.,
2012). Labels of this type are known as 3-hydroxychromone
(3HC) probes (reviewed in Klymchenko et al., 2012). They are
unique among the peptide fluorescent labels as they undergo
rapid excited-state intramolecular proton transfer (ESIPT,
Figure 1C). Both, normal (N*) and tautomeric (T*) excited
states exhibit discrete emission bands, the position and relative
intensity of which are sensitive to the environment. In particular,
polar and H-bonding media suppress the ESIPT, thus decreasing
the relative intensity of the T* band. Therefore, double-emission
labels such as the FHC-amino acid are considered superior for
studies of biological systems (Pivovarenko et al., 2012). Such
ratiometric fluorescent probes can be incorporated in place of
natural amino acid residues to convey information about the
peptide and its immediate surroundings through several
channels, as opposed to single-channel intensometric probes.
3HC-derived labels have already demonstrated excellent
performance in studies of AMP interactions with model lipid
bilayers and cell membranes (Postupalenko et al., 2011;
Postupalenko et al., 2013; Zamotaiev et al., 2014), where only
a few efficient instrumental methods currently exist.
Lastly, we desired to cause minimal perturbations to cWFW
upon labeling. Although several 3HC-based amino acids that are
superior to FHC in their spectroscopic characteristics have been
described to date (Zamotaiev et al., 2011; Postupalenko et al.,
2013; Sholokh et al., 2015), we chose FHC because this molecule is
the most compact and, except for the hydroxycarbonyl moiety,
possesses no other reactive groups in the side-chain that could
further affect the peptide structure and functions. Additionally, in
comparison against other known 3HC probes, FHC residue
possesses hydrophobicity coefficient LogPC closest to
tryptophan and phenylalanine. Therefore, we envisaged that
FHC should be most appropriate to substitute aromatic
residues in cWFW, highlighted by color in Figure 1A.
MATERIALS AND METHODS
Ethical Statement
The experimental design complied with European Legislation for
the Protection of Animals used for Scientific Purposes (Directive
2010/63/EU). All experiments with Danio rerio were performed
on larvae less then 120 h postfertilization (hpf), which does not
require an ethical commission approval (Afonin et al., 2020).
Experiments were performed following the relevant German
animal protection standards.
Materials
All chemicals were purchased from Sigma-Aldrich, Iris Biotech or
Biosolve and were used without further purification. Ultrapure
deionized (MilliQ, Millipore) water was used to prepare aqueous
solutions and mixtures. Solvents for peptide purification and
optical spectroscopy were of HPLC grade and were degassed
before use. Culture media and supplements for animal cells were
from Thermo Fisher, those for bacterial culturing were from
Becton, and those for zebrafish embryo handling were freshly
prepared. Citrate phosphate dextrose-stabilized blood bags with
erythrocyte suspensions of healthy donors for hemolysis assays
TABLE 1 | Nomenclature, sequences, and characterization data of the peptides studied in this work.
Peptide Sequence Calc. massa [u] Obs. Mass [u] RTb [min]
cWFW cyclo[Trp
1-Phe2-Trp3-Arg4-Arg5-Arg6] 988.17 988.3 9
cRW-W1/FHC cyclo[FHC
1-Phe2-Trp3-Arg4-Arg5-Arg6] 1,098.66 1,099.2 11
cRW-F2/FHC cyclo[Trp
1-FHC2-Trp3-Arg4-Arg5-Arg6] 1,137.68 1,138.0 10.5
cRW-W3/FHC cyclo[Trp
1-Phe2-FHC3-Arg4-Arg5-Arg6] 1,098.66 1,099.3 11
aCalc. and obs. masses are listed for [M + H]+ ions as measured in positive mode MALDI-TOF-MS.
bRT  apparent retention time as determined on C18 phase by HPLC with a 1% B/min gradient slope.
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were obtained from the blood bank of the Karlsruhe municipal
hospital.
Cell Cultures
Bacillus spizizenii (DSM 347) and Escherichia coli (DSM 1116)
were purchased from the German Collection of Microorganisms
and Cell Cultures. The bacterial strains were maintained frozen at
−80°C using a bacterial Cryobank System (Mast Diagnostica). To
refresh bacterial cells on single glass beads, they were grown
overnight in Müller-Hinton (MH) medium, and colonies were
obtained by streaking on MH agar. Then, colony cells were used
to inoculate MH broth up to OD  0.02 and grew at 37°C
overnight. These overnight cultures were used to inoculate the
test culture, which was grown for 3–4 h until it reached
exponential growth. HeLa (ECACC 93021013) and HEK293
(ECACC 85120602) cells were purchased from American Type
Culture Collection and were routinely cultured in Roswell Park
Memorial Institute (RPMI) 1640 medium or Dulbecco’s modified
Eagle medium (DMEM) supplemented with 10% fetal calf serum
(FCS) and 1% penicillin/streptomycin, respectively. Cells were
passaged every 2–3 days and used until passage 35. All animal cell
types were cultured at 37 °C in a 5% CO2 atmosphere and tested
negative for mycoplasma.
Zebrafish Embryos
All experiments were performed using wild-type (strain AB)
Danio rerio. Zebrafish housing and husbandry were performed
following the recommendations by (Aleström et al., 2020).
Fertilized eggs (6 hpf) were raised in 4ml of embryonic
medium (E3, 5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2,
0.33 mM MgSO4, 0.1% methylene blue) at 28 °C until 72 hpf




The synthesis of Fmoc (fluorenylmethyloxycarbonyl)-protected
FHC followed procedures described in (Strizhak et al., 2012).
Solid-Phase Peptide Synthesis
Peptides were synthesized with a BiotageSyro II automatic
peptide synthesizer using standard solid-phase Fmoc protocols.
The linear sequences were synthesized on a 2-chlorotrityl (2CT)
resin preloaded with the first amino acid arginine (H-L-Arg
(Pbf)-2CT resin). The resin (200–400 mesh) load was
0.5 mmol/g; the synthesis scale was 0.2 mmol. The sequences
for the linear peptides were as follows: linearWFW: H-Arg (Pbf)-
Arg (Pbf)-Arg (Pbf)-Trp (Boc)-Phe-Trp (Boc)-NH2, linearRW-
W1/FHC: H-Arg (Pbf)-Arg (Pbf)-Arg (Pbf)-FHC(Ac)-Phe-Trp
(Boc)-NH2, linearRW-F
2/FHC: H-Arg (Pbf)-Arg (Pbf)-Arg
(Pbf)-Trp (Boc)-FHC(Ac)-Trp (Boc)-NH2, and linearRW-W
3/
FHC: H-Arg (Pbf)-Arg (Pbf)-Arg (Pbf)-Trp (Boc)-Phe-
FHC(Ac)-NH2. For standard α-amino acids, double coupling
with 4 equiv was used. Fmoc-protected amino acids were
activated with HBTU (2-(1H-benzotriazol-1-yl)-1,1,3,3-
tetramethyluronium hexafluorophosphate) and HOBt
(1-hydroxybenzotriazole) using N,N-diisopropylethylamine
(DIPEA) in N-methyl pyrrolidone (NMP) as the reaction
solvent. Fmoc deprotection in all cases was performed with
20% piperidine in NMP. The coupling of the fluorescent
amino acid was performed manually at selected positions
using 1.2 equiv. of Fmoc-FHC, activated with 1.2 equiv of
PyOAP (7-azabenzotriazol-1-yloxy)tripyrrolidino-
phosphonium hexafluorophosphate) and 2.4 equiv of DIPEA
in N,N-dimethylmethanamide. Then, the resin was washed
with DMF and acylated (0.5 ml acetic anhydride, 4 ml DMF
and 1 ml DIPEA, 15 min). Following acylation, the resin was
extensively washed with NMP and synthesis was continued on
the peptide synthesizer. After completion of a linear sequence, the
resin was washed with DCM and dried under vacuum. Linear
precursors were cleaved from the resin without side-chain
deprotection by a mixture (1:3, v/v) of HFIP (1,1,1,3,3,3-
hexafluoropropan-2-ol) and methylene chloride (DCM). The
resulting solution was filtered from the resin and dried using a
rotary evaporator. The obtained oil was suspended in an
acetonitrile/water mixture (1:1, v/v) and lyophilized. The
cyclization step was performed in DCM (0.8 L per 0.2 mmol
load) with the activating mixture of PyOAP (2 equiv) pre-
dissolved in DMF, followed by the addition of DIPEA (4
equiv). The reaction mixture was stirred overnight. The
solvent was removed on a rotary evaporator, and the residual
material was lyophilized. The final deprotection of the cyclized
peptides was performed with a deprotecting cocktail containing
trifluoroacetic acid (TFA), triisopropylsilane, and water (95:2.5:
2.5, v/v/v). The volatiles were removed on a rotary evaporator,
and the residual oil was suspended in acetonitrile/water and
lyophilized.
The peptides were purified (>95%) by reversed-phase high-
performance liquid chromatography (HPLC) employing C18
stationary phase columns (Vydac) and TFA-supplemented
(0.1% v/v) water/acetonitrile gradients (4% eluent B/min)
without temperature control on a Jasco HPLC system
equipped with a diode array detector. Analytical
chromatography was performed using the same stationary/
mobile phase conditions, employing temperature control
(column temperature 40°C) and shallower gradients (1%
eluent B/min). All peptides and individual HPLC fractions
were characterized by matrix-assisted laser desorption/
ionization time-of-flight mass spectrometry (MALDI-TOF MS)
using a Bruker Autoflex III instrument in positive reflector
detection mode and with α-cyano-4-hydroxycinnamic acid as
a matrix. From pure peptide powders, stock solutions were
prepared (1 mg/ml) in 30% aqueous acetonitrile and stored at
−80°C. For spectroscopy, imaging and bioactivity measurements,
aliquots from these solutions were taken a day before the
experiment, and peptide samples containing the necessary
amount of peptide dry material were obtained by
lyophilization overnight.
Circular Dichroism Spectropolarimetry
Salt-free phosphate buffer (PB, 10 mM, pH 7.4), 2,2,2-
trifluoroethanol (TFE), or 10 mM aqueous sodium lauryl
sulfate suspension were added to dry peptides (final
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concentration 100 µM), vortexed and incubated for 30 min at
r.t. In the form of large unilamellar vesicles (LUVs), liposomes
were prepared by conventional extrusion at a 2 mM
concentration of the total lipid in PB. Extrusion was
performed at 35°C through 0.1 µM polycarbonate
membranes (Nucleopore) using Avanti Mini Extruder.
Stable LUV suspensions were obtained either from 8:2 M
mixture of 1,2-dimyristoyl-sn-glycero-3-phosphocholine
(DMPC) with cholesterol, or from 1:1 M mixture of DMPC
with 1,2-dimyristoyl-sn-glycero-3-phospho-(1′-rac-glycerol
(DMPG). The former mixture mimics a typical zwitterionic
“animal”membrane lipid composition; the latter represents an
anionic “bacterial” membrane model counterpart. LUV
suspensions were gently mixed with the 200 μM PB
solutions of peptides and incubated for 30 min at 35°C to
allow membrane binding above lipid mixture melting
temperatures. CD spectra were measured on a J-815 Jasco
spectropolarimeter. The measurements were performed in
quartz glass cells (Hellma) with a 1 mm path length
between 260 and 185 nm at 0.1 nm intervals. Spectra were
recorded at 25°C and for LUVs at 35°C using a water-
thermostatted rectangular cell holder. Three repeat scans at
a scan rate of 20 nm/min, an 8 s response time and a 1 nm
bandwidth were averaged for each spectrum. After subtracting
the baseline (peptide-free samples), CD data were processed
with Jasco Spectra Analysis software.
Spectroscopic Measurements
Dry peptides were dissolved in ultrapure deionized water, PB,
TFE, ethanol or DMF to a concentration of 8 µM. Baseline-
corrected absorption spectra were recorded at r.t. in single-
beam mode on a Cary 4000 UV–visible (UV-VIS)
spectrophotometer (Varian) using 500 µl volume, 10 mm
light-path length quartz glass cells (Hellma). Fluorescence
measurements were performed immediately after UV-VIS
measurements on a FluoroMax2 spectrofluorometer
(HORIBA Jobin Yvon) equipped with a thermostated cell
compartment without cell exchange (excitation wavelength
varied; typically, 1 nm slits were used for both excitation
and emission channels). The data were processed and
analyzed in OriginPro 2020b.
Bacterial Growth Inhibition Assay
The bacteriostatic activity of the peptides was characterized by
determining minimal culture growth inhibitory concentrations
(MICs) in planktonic cultures. Serial twofold dilutions of each
peptide (in-well concentration range: 128 μg/ml to 2 mg/ml) were
prepared in MH broth and aliquoted into round-bottom 96-well
microtiter plates (Sarstedt). Each well was inoculated with a
standardized inoculum to achieve a final test concentration of
approximately 106 cells/ml. The MIC was measured as the lowest
concentration of the peptide that completely inhibited visible
bacterial growth after incubation at 37°C for 20 h and was further
confirmed by resazurin staining (addition of 20 µl of 0.2 mg/ml
resazurin to each well and incubation at 37°C for an additional
2 h). The measurements were repeated twice with three replicates
each time.
Hemolysis Assay
Hemolytic activity was examined using the same serial twofold
dilution concentrations as for the MIC assay. The erythrocytes
were washed with isotonic Tris-HCl buffer (pH 7.6, 37°C) diluted
to a 0.5% hematocrit, equal volumes of peptide Tris-HCl buffer
solutions were added, and mixtures were incubated at 37°C for
30 min with gentle shaking. The tubes were centrifuged at
13,000 rpm for 10 min to pellet the cells, and the absorbance
at 540 nm was recorded against a negative control (cells without
peptide, accounting for autohaemolysis). The lysis percentage was
calculated relative to lysis levels induced by 1% (v/v) Triton X-
100. The absorbance measurements were repeated five times, and
the averaged values were used.
Cell Viability by Fluorescent Staining
A day before imaging, cells were split and transferred to 4-well
borosilicate microscopy chambers (chambered cover glass from
LabTek), allowed to adhere and cultured in RPMI or DMEM at
37°C, 5% CO2, 10% FCS, and 1% penicillin/streptomycin. For
imaging, each well was washed with Leibovit’s L-15 (L-15)
medium without phenol red and other supplements; 500 µl of
a freshly prepared L-15 solution of peptides was applied to each
well, and chambers were incubated at 37°C in a 5% CO2
atmosphere. Imaging was performed at 37°C without CO2
supplementation. To quantify cell viability (2.5 h after peptide
addition), an additional 500 µl of L-15 solution of propidium
iodide (PI) and Hoechst 33342 (Hoechst) was added to each well
(the final concentrations were 1 μg/ml for PI and 3 μg/ml for
Hoechst). After a 10 min incubation, images were acquired at 20×
magnification using laser excitation at 405 and 488 nm. Three
images per well at randomly chosen positions were collected.
Maximum-intensity projections of the z-stacks around the
highest cell density focal plane were generated and analyzed
using ImageJ/Fiji software.
Fluorescence Microscopy
For peptide imaging, cell cultures were treated, and peptides were
applied as described above. In cell culture experiments, z-stack
image acquisition was performed with either a Z1 Cell Observer
spinning disc inverse microscope (Zeiss) or an inverse confocal
laser scanning microscope SP8 (Leica Microsystems), both
equipped with a 20× NA 0.75 water or 63× NA 1.4 oil
immersion objective and several solid-state excitation lasers,
including a 405 nm laser.
For intravital imaging, anesthetized living three dpf zebrafish
embryos were embedded, with the right lateral side of the embryo
facing upward, into 0.8% (w/v) low-melting agarose (Lonza) in
35 mm glass-bottom microscopy dishes (MatTek). The agarose
was covered with E3 medium supplemented with 0.017% (w/v)
tricaine methanesulfonate and 0.003% (w/v) 1-phenyl-2-thiourea
for anesthesia and background fluorescence reduction,
respectively. For injections, peptides were prepared as 100 µM
solutions in PBS. Each solution was injected (ca. 8 nL) with
borosilicate glass capillary tubes (∼0.6 mm diameter) into the
common cardinal vein of the immobilized subjects with a gas-
driven microinjector (Eppendorf Femtojet express), and dishes
were transferred to the microscope where images were acquired at
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r.t. using an SP8 upright confocal microscope (Leica
Microsystems) equipped with a tunable white light laser for
double-photon excitation. Leica instruments were equipped
with LAS X software for image acquisition. Maximum
intensity projections were generated and analyzed using
ImageJ/Fiji software.
RESULTS AND DISCUSSION
Validation of the Label
An essential step of all studies involving peptide labeling is the
validation of the label. It should be confirmed that the label,
incorporated instead of an appropriate peptide fragment, disturbs
neither the parent peptide structure nor functions significantly.
For the small, constrained cWFW peptide, choosing such a non-
disturbing label is a challenging task. This peptide has already
been studied using intensometric fluorescent labels incorporated
in place of aromatic residues (Scheinpflug et al., 2013). In most
known cases, any modifications by the fluorescent probes led to
drastic changes in the cWFW structure and biological activity
compared to the original cWFW sequence. These data were
decisive for our choice of the label, the amino acid FHC, and
we first verified experimentally if our choice was justified.
To compare individual aromatic substitutions, we synthesized
three cWFW analogues (Table 1), where the FHC residue
substituted for W1, F2, or W3 in the parent peptide.
Gratifyingly, N-Fmoc-FHC demonstrated excellent
compatibility with Fmoc solid-phase peptide synthesis (SPPS)
protocols.
Conformational preferences of the three labeled peptides were
evaluated in different environments using CD spectropolarimetry
and were then compared with the parent peptide. We measured
the CD spectra in PB (10 mM, pH 7.4, 25°C), in 100% TFE, in the
presence of detergent micelles (SDS, excess), and in the presence
of prokaryotic or animal membrane composition mimicking
LUVs, to determine whether the environment affects the
conformation of the cWFW-derived analogues and to model
conditions of the following in vivo studies. As shown in Figure 2,
all the peptides revealed CD patterns compatible with a
combination of turn-like structures (Bagheri et al., 2011;
Hernańdez et al., 2012), as would have been expected for a
cyclic hexamer peptide. Since all peptides, including cWFW,
exhibited different CD lineshapes in different environments,
one may assume a certain degree of conformational freedom
in the peptide backbone, despite its cyclic and thus backbone-
constrained nature. The CD spectra revealed that the nature of
the environment strongly affects conformational equilibria; in
FIGURE 2 |CD spectra of the peptides in various environments (top to bottom traces): in 10 mMphosphate buffer, pH 7,4, in 2,2,2-trifluoroethanol (TFE), in 10 mM
sodium dodecyl sulphate (SDS) micelles at a peptide/detergent ratio (P/D) of 1/100, in the presence of large unilamellar vesicles (LUVs) modeling an “animal” (DMPC/
cholesterol, 4/1) or a “bacterial” (DMPC/DMPG, 1/1) plasma membrane in terms of the lipid composition. The spectra were acquired from fresh 100 µM (or 200 µM for
LUVs) peptide solutions at 25°C or 35°C (LUVs). P/L designates peptide/lipid ratio.
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particular, the averaged conformation of each peptide was very
different in aqueous and membrane-mimicking environments.
We also noted that all peptides demonstrated similar overall
lineshapes in each of the two isotropic solutions (Figure 2 top two
rows). However, an exact match to the parent cWFW was not
observed in any of the analogues for the entire conditions set.
cRW-F2/FHC was the most deviant from cWFW under the tested
conditions. In contrast, both Trp/FHC-substituted peptides
appeared to be folded similarly to cWFW, and we note that
both analogues fold most similarly to the parent cWFW in the
presence of an “animal” cell membrane surrogate.
In the next step, we tested various biological activities of the
labeled peptides, namely, their bacteriostatic, hemolytic, and cell-
penetrating abilities. The latter has never been measured for a
nonlabelled cWFW, whereas the first two activities had been
severely compromised upon labeling, as reported in previous
studies (Scheinpflug et al., 2013).
We measured the minimum inhibitory concentrations (MIC
values) for the peptides using two representative bacterial strains:
a gram-negative E. coli and a gram-positive B. spizizenii–by a
standard twofold dilution assay. The results are shown in
Figure 3A. All labeled peptides demonstrated equal (within
the experimental errors) bacteriostatic activity, which was still
relatively high and differed from the MIC of cWFW by two
dilutions. The best-performing fluorescent label used previously,
nitrobenzoxadiazole-modified diaminopropionic acid, had
caused a decrease in bacteriostatic activity by three to four
dilutions (Scheinpflug et al., 2013). Interestingly, despite
pronounced conformational differences (Figure 2), all the
labeled analogues were indistinguishable in terms of their MIC
values.
In contrast, the hemolysis assay revealed different activities of
the labeled peptides compared to cWFW. All three labeled
analogues appeared more hemolytic than the parent molecule.
The peptide cRW-F2/FHC was the most active among the series,
showing hemoglobin releasing potency compatible with the
previously studied fluorescent cWFW analogues (Scheinpflug
et al., 2013). The two Trp/FHC-substituted peptides revealed
significantly lower hemolysis values. Hemolytic activity did not
correlate with the overall hydrophobicity of the peptides (as
assessed by HPLC retention time, see Table 1). In our hands,
cRW-F2/FHC was the most hemolytic but was less polar than
both Trp/FHC analogues.
Next, we incubated the fluorescent cWFW analogues with an
adherent HeLa cell culture and compared the ability of the
peptides to enter the cells by confocal fluorescence
microscopy. As shown in Figure 3C, FHC-labeled peptides
indeed entered the cells, demonstrating both cytosolic and
microsomal entry. No differences were observed among the
three cWFW analogues. We also noted that the overall cell
entry (cell staining) was not uniform, as some cells were
stained more intensely than the others.
From the studies described in this section, we concluded that
FHC exerts modest perturbation of the structure and functions of
FIGURE 3 | (A) Planktonic bacterial growth inhibition according to a broth microdilution assay. Numbers depict µM values calculated from µg/ml dilutions; (B)
concentration-dependent hemoglobin release from human erythrocyte suspension; and (C) fluorescence microscopy observation of Hoechst 33342 (blue color)-co-
stained Hela cells after 1 h of incubation with 30 µM FHC-labelled cWFW analogues (green color). Images are 105 × 114 µm.
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the parent peptide cWFW. These perturbations are less drastic
than those reported previously for this peptide; hence, our choice
of the label is justified for the present study. Among three
analogues, cRW-W3/FHC overall appeared to behave closest to
the parent peptide.
Photophysical Properties of Fluorescently
Labeled Peptides
To explore the environmental sensitivity of the fluorescent
spectral parameters of the FHC-labelled peptides, we collected
their fluorescence spectra (under excitation at 365 nm) in PB,
TFE, and ethanol (data not shown). These spectra confirmed the
dependence of the position and relative intensity of the T*/N*
emission bands on the solvent polarity and H-donor ability.
However, many confocal microscopes are not equipped with
UV lasers exciting at wavelengths lower than 405 nm; hence,
we tried to observe the fluorescence of the same samples using
excitation at 405 nm. Surprisingly, we observed a significant
deviation of the emission spectra from those obtained under
365 nm excitation. Therefore, in the next set of experiments, we
systematically addressed the spectral characteristics of the
peptides. First, we compared the fluorescence spectra of all the
labeled peptides at 370 and 405 nm excitation in solvents of
different polarities, water and DMF (Figure 4).
Under excitation at 370 nm in water, the T*/N* band intensity
ratio was influenced by the position of the label in the peptide
sequence. The two Trp/FHC-substituted analogues revealed
comparable ratios in their emission spectra. In contrast, the
spectrum of cRW-F2/FHC appeared to possess a lower T*/N*
band ratio, correlating with the outstanding conformational
behavior and higher hemolysis rate observed for this peptide.
Together with the lower fluorescence intensity, this spectral
change may reflect a more hydrated local environment of the
F2/FHC residue in this analogue, suggesting a much higher
number of water molecules around the residue in this position
(FHC in the labeled analogue or Phe in the wild-type peptide). It
is well known that in aqueous surroundings, both the quantum
yields and the T*/N ratios of 3HC dyes diminish (Klymchenko
et al., 2007; Klymchenko et al., 2008); therefore, it is plausible that
the residue at this position is more exposed on average to bulk
water than its immediate neighboring residues.
FIGURE 4 | Fluorescence spectra (not normalized) from 8 µM solutions of the FHC-labeled cWFW analogues in H2O and DMF under different excitation
wavelengths (indicated as “Ex 370 nm” and “Ex 405 nm”).
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In the spectra excited at 405 nm in water, we observed the
opposite scenario: the double-emission spectrum of cRW-F2/
FHC appeared to possess the highest T*/N* band ratio,
suggesting the lowest number of water molecules surrounding
the fluorophore. It appears, therefore, that the conformational
equilibrium of cRW-F2/FHC in water should include at least two
dominant conformations: in the former, the FHC residue is
exposed to the bulk water, and in the latter, it is partially
shielded by the other amino acid residues.
Next, we note that for all analogues, the overall fluorescence
intensity remained similar in both solvents at 370 nm excitation.
However, the signal was an order of magnitude brighter in DMF
than in water under 405 nm excitation. Taking into account the
generally higher quantum yields of the FHC fluorophore in DMF
(Klymchenko and Demchenko, 2004; Klymchenko et al., 2008)
and the higher basicity of DMF compared to water (Reichardt
and Welton, 2019), the observed intensity difference can be
explained by an alternate distribution of the ground-state
tautomers of FHC (Figure 1C) in the two solvents or by
anion formation of FHC. It has been previously shown for the
parent 2-furylchromones that the anionic form of the dye could
be present in measurable quantities even at pH 7.4 (Klymchenko
and Demchenko, 2004). The species were assigned by absorption
maxima of 413 nm for the anionic forms and 358 nm for the
neutral forms in that model study. In our experiments under
405 nm excitation, an increase in fluorescence intensity in DMF
FIGURE 5 | Intensity-normalized absorbance spectra from 8 µM solutions of the FHC-labelled cWFW analogues in solvents of different polarities, colored
according to the polarity index (Reichardt and Welton, 2019, insert, “a)”). Black arrows mark excitation wavelengths used for fluorescence measurements and
microscopy (370 and 405 nm).
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was observed for all peptides, allowing the assumption that these
spectra correspond to the emission of the much brighter anionic
form (however, see the discussion below).
The excitation wavelength-dependent change in the
fluorescence of our peptides prompted us to examine their
absorption properties in more detail. We recorded UV-VIS
spectra for the peptides in solvents of different polarities
(Figure 5). Surprisingly, we detected significant
solvatochromism in the absorption spectra of our 3HC-
containing peptides. A notable observation was the ∼90 nm
bathochromic shift of the absorbance maxima upon changing
the solvent from H2O to DMF. When water and DMF were the
solvents, the spectral difference correlated with the emission
changes. Additionally, this might be explained as a result of
the increased pH at the location of the FHC chromophore,
leading to an increased population of the ground state anionic
form. A consecutive increase in the solvent basicity explains
spectral changes in the order: water > PB (Klymchenko and
Demchenko, 2004) > ethanol >DMF. However, the extreme shift
of the absorbance maximum of the anionic form to 455 nm in
DMF and an intermediate spectral shape in TFE (which is more
acidic than water (Sierra et al., 2005; Reichardt andWelton, 2019)
cannot be explained by the changes in polarity or basicity of the
solvent alone. In DMF, in particular, both forms of the FHC
chromophore, neutral and anionic, were reported to absorb at
much lower wavelengths (Klymchenko and Demchenko, 2004;
Klymchenko et al., 2007). We suggest that this abnormal redshift
of the absorption maxima may result from intramolecular side-
chain/side-chain interactions. Guanidinium groups of the
cationic arginyls can be in close proximity to the FHC residue,
promoting the anionic form and modulating the fluorescence
quantum yield. Similar stabilization of the chromophore ground
state accompanied by a substantial increase in the fluorescence
quantum yield was reported earlier for complexes of a 3HC with
the tetracharged anion of adenosine-5′-phosphate (Pivovarenko
et al., 2017). Molecular modeling corroborates this suggestion: the
constrained cWFW backbone can still allow Arg-FHC
interactions (Figure 6).
Overall, we suggest that in aqueous solutions, the cWFW
analogues (and possibly cWFW) exist in more than one
conformation, including a structure with aromatic side-chains
residing near the charged residues (“closed” state, Figure 6A).
Peptide molecules in this conformation should be those that
absorb light at 390–470 nm and are adequately excited at 405 nm.
This pool of molecules gives an intense emission peak in the
fluorescence spectrum at 490–520 nm. The alternative
conformational set, where the aromatic side-chains may
participate in various mutual π-π interactions, pointing away
from the charged groups of the arginine residues (“open” state,
Figure 6B), should be responsible for the double-emission
spectrum, with maxima at approximately 430 and 530 nm.
These suggestions do not contradict the results of the NMR
FIGURE 6 | Orthogonal projections of the two energetically preferred conformations in vacuo of the peptide cRW-F2/FHC, according to an MM+ molecular
modeling run: (A) “closed” state, where all three arginyls interact with the FHC side-chain, and (B) “open” state, where the arginyl cluster and the aromatic side-chains are
well separated. The FHC residue is in green and CPK. Trp1 and Trp3 are in dark and light blue, respectively. The residues interacting with FHC are shown in CPK
rendering mode.
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structural studies of cWFW in different environments (Appelt
et al., 2008) nor our CD data.
Changing of the environment from aqueous to less polar can
promote shifting the conformational equilibria toward
conformations with effective WFW-RRR side-chain
interactions, as seen from the UV-VIS absorption spectra and
from the presence of the emission peak at 490 nm in the
fluorescence spectra of all analogues under 370 nm wavelength
excitation. Therefore, this peak is assigned to the Arg-stabilized
anionic form of the FHC fluorophore in the “closed” state.
Collectively, excitation of the FHC-labelled cWFW analogues
at 370 nm provides a fluorescence response mainly from the
“open” state conformations since the fluorescence intensity from
the “closed” states is weak (∼10–20% of total intensity). Excitation
at 405 nm will mainly sample the molecules in “closed”-like
states.
Cell Entry and Cytotoxicity of cWFW
Analogues Studied in Human Cells
Next, we continued to study the peptide-cell interactions by co-
incubating the labeled cWFW analogues with adherent cells,
comparing different cell lines (HeLa cancer line vs HEK293
noncancer line), and varying peptide concentrations
(1–60 µM), and incubation times (5 min–2.5 h). To assess the
polarity of the media surrounding the FHC residue, we recorded
the emissions separately within a spectral range corresponding to
the N* (415–480 nm) and T* (490–555 nm) bands, as well as the
total 416–600 nm signal. Due to the constructional peculiarities of
the confocal microscope used, the excitation in these experiments
was performed using the 405 nm laser.
As shown in the representative images (Figures 7, 8A),
detection within the three different spectral ranges at the
chosen magnification revealed the same signal patterns, which
differed only in absolute intensity. This fact should correspond to
a low N*/high T*-emission, characteristic of a decreased polarity
of the FHC-surroundings. In a living animal cell, the membranes,
lipid droplets, and supramolecular protein complexes in the
cytoplasm may provide such environments.
Immediately after peptide addition (∼5 min incubation), a
strong signal associated with the plasma membranes was
visible for both types of cells. Following 1 h of incubation, the
images changed. In HeLa cells, the cell boundaries remained
barely visible, while much stronger cytosolic and microsome-
associated signals emerged. We noted that the cell nuclei
remained unstained by the labeled peptides under all
FIGURE 7 | Band-filtered confocal fluorescence images of adherent HeLa and HEK293 cell cultures incubated with 30 µM cRW-W3/FHC for 5 and 60 min
(indicated). Spectral ranges for collecting emission data are shown at the bottom of the image stacks; BF  bright-field images.
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conditions studied. This behavior in HeLa cells was observed in
the entire concentration range of 1, 20, 30, and 60 µM for all
peptides, independent of the FHC-fluorophore position. In
contrast, HEK293 cells retained the fluorescence mainly in the
plasma membranes even after prolonged (2.5 h) incubation with
the peptides. We conclude from these observations that cWFW
analogues efficiently entered cancer cells but not the
noncancerous undifferentiated cells.
The occurrence of bright, uniformly stained cells with
unusual morphology that we observed upon incubation of
both, HeLa and HEK293 cells, with the labeled peptides could
correspond to necrotic cells. As can be assessed from the
hemolytic activity data (Figure 3), the Trp/FHC-substituted
peptides cause the death of >25% erythrocytes at a 30-µM
concentration, and even more (>50%) in the case of the Phe/
FHC-analogue. We used a method based on fluorescence
microscopy to quantify the cytotoxic potency against HeLa
and HEK293 cells under imaging conditions. After cell-entry
imaging, i.e., after 2.5 h co-incubation, we incubated the cells
with Hoechst and PI (propidium iodide). Imaging the
Hoechst (blue) and PI (red) staining revealed, respectively,
the total cell number and the membrane-damaged,
apparently, necrotic cells. Representative images and the
results of these experiments are illustrated and
summarized in Figure 8.
Contrary to the haemolysis results, we observed that the
labeled cWFW analogues demonstrated relatively low toxicity
(<5% at 20 µM) against HeLa cells. In the case of HEK293 cells,
the cytotoxicity was slightly higher and comparable to the cWFW
toxicity. The peptides killed 5–10% of the HEK293 cells at 20 μM,
but this activity was still lower than the hemolytic activity
(Figure 3).
FIGURE 8 | Cytotoxicity evaluation of cWFW and its fluorescent analogues by fluorescence microscopy. (A) First, at higher magnification (63× objective), the cells
were imaged to monitor cell entry of the peptides; HeLa cells with 20 µM peptide imaging after 1 h of incubation are shown for illustration. (B) After imaging (2.5 h after
peptide addition), Hoechst/PI co-staining is applied and imaged at 20×magnification, exemplified here by experiments with HEK293 cells; (C) Total/dead cell counting
results for all peptides at 20 µM concentration co-incubated with both cell types.
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The Biodistribution of Peptides in Vivo
After confirming the low toxicity of the fluorescently labeled peptides
against animal cells, we administered the compounds to four dpf
zebrafish embryos via intravenous injection. A total of 8–10 nl of
100 µM peptide solution in PBS was applied to every agarose-
immobilized subject, followed by confocal imaging after 30min of
incubation. The biodistribution of each peptide was analyzed in XYZ
dimensions by detecting fluorescent signals emitted in a range of either
415–435 nm or 470–520 nm followed by sequential two-photon
excitation at 730 and 810 nm, roughly corresponding to 365 and
405 nm single-photon excitation, respectively (representative images
are shown in Figure 9).
With the applied procedure, we did not detect any signs of
toxicity during 3 h of imaging. There was also no pronounced
difference between the peptides. For all of the peptides, we
observed fluorescence intensity associated only within the
blood vessels. Interestingly, assessment of the T*/N* band
intensity ratio, similar to the cell experiments described above,
revealed a local hydrophobic environment around the FHC-label.
At the same time, we see that the peptides remained in the blood.
This observation suggests that the cWFW analogues were not
dissolved in the plasma. Instead, they must have associated most
likely with blood lipoproteins, apoptotic bodies, exosomes and/or
microvesicles (Hyenne et al., 2019), while not binding
significantly to the cellular fraction in the blood.
CONCLUSION
In summary, we have validated a known 3-hydroxychromone-
derived dual-fluorescent amino acid FHC as a “good” peptide
label for in vitro and in vivo studies of peptides in bio-objects,
useful even in the highly constrained context of an ultrashort
cyclic hexameric peptide. This label can deliver valuable
information on conformational behavior, localization, polarity
of the environment, basicity, and the H-bond donating/accepting
ability of the molecules in close vicinity to the fluorophore
through various spectroscopic and fluorescence imaging
techniques. The use of the FHC label in the antimicrobial
peptide cWFW revealed a cell-penetrating activity of this
peptide toward the cancerous cell line HeLa. This functionality
correlates well with its observed localization in cellular
membranes or other cellular components with low polarity.
The same label also helped to localize the peptide in a living
model organism, the D. rerio embryo, and characterize its
microenvironment. The cytotoxic effects of cWFW and its
fluorescent analogues toward cancerous cells were not high
enough to consider these peptides as possible anticancer
agents. However, given the great potential of cWFW as an
antimicrobial drug candidate, our observations of the
interactions of cWFW analogues with animal cells and the
multicellular organism described above provided meaningful
FIGURE 9 | Orthogonal section views from four dpf zebrafish embryos injected with either cWFW in PBS (A–D) or cRW-W3/FHC peptide (E–H). The trunk region
was imaged by detecting emitted fluorescence light in a range of either 415–435 nm (A, C, E, G) or 470–520 nm (B, D, F, H) after sequential two-photon excitation at
730 nm (A, B, E, F) and 810 nm (C, D, G, H). Sagittal sections (A–H), transverse sections (A9–H9) and horizontal sections (A99–H99) are shown. Dashed lines (magenta) in
sagittal views indicate the position where horizontal views were made. Arrows indicate the caudal artery, where cRW-W3/FHC and other peptides were mainly
found to be localized. Scale bar: 50 µm.
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data. In particular, the confinement of the labeled cWFW
analogues to the bloodstream and their inefficient
penetration into tissues, as observed in the experiments
with D. rerio, suggest the need for further optimization of
formulations for this compound to improve its in vivo
biodistribution. Further experiments using herein designed
FHC-labelled analogues and possibly other HC-based
derivatives might also clarify the molecular details of the
cWFW peptide conformational equilibria in various native
and model environments and provide valuable insights into
the mechanisms of antibacterial and other bioactivities.
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